CG Oncology, Inc. Common stock (CGON) financials · rev $4.0M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
CG Oncology, Inc. Common stock (CGON) rev $4.0M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $4.04M | $1.14M |
| Operating Income | -$190.8M | -$114.7M |
| Net Income | -$161.0M | -$88.0M |
| EPS (Diluted) | -$2.08 | -$1.41 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $791.6M | $754.8M |
| Current Assets | $759.5M | $754.2M |
| Cash & Equivalents | $32.5M | $257.1M |
| Inventory | $1.56M | $0 |
| PP&E | $15.6M | $272.0K |
| Total Liabilities | $39.0M | $21.4M |
| Current Liabilities | $30.8M | $21.4M |
| Long-term Debt | $3.00M | N/A |
| Total Debt | $3.00M† | N/A |
| Shareholders' Equity | $752.6M | $733.4M |
| Retained Earnings | -$379.0M | -$218.0M |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$132.3M | -$78.7M |
| CapEx | $134.0K | $234.0K |
| Investing Cash Flow | -$245.8M | -$300.8M |
| Financing Cash Flow | $153.6M | $628.3M |
| Net Change in Cash | -$224.6M | $248.8M |
| Free Cash Flow | -$132.5M | -$78.9M |
FAQ
What is CGON P/E and revenue?
CG Oncology, Inc. Common stock (CGON) rev $4.0M.
What is CGON revenue?
CG Oncology, Inc. Common stock last cached revenue is $4.04M (FY2025).
Is CGON profitable?
CG Oncology, Inc. Common stock last cached net income is -$161.0M (FY2025).
What are CGON total assets?
CG Oncology, Inc. Common stock last cached total assets are $791.6M (FY2025).
What is CGON free cash flow?
CG Oncology, Inc. Common stock last cached free cash flow is -$132.5M (FY2025).
Not investment advice. Cached statements, not a live tape.